Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

The FDA has approved berotralstat oral pellets for prophylactic use in patients aged 2 to than 12 years with hereditary ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

KYMR gains momentum as the FDA grants Fast Track to KT-621 for moderate to severe atopic dermatitis, boosting the stock and advancing its Type 2 pipeline.

GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GSK has announced that the European Medicines Agency’s Committee for Medicinal Products for ...

Choosing vaccination cannot guarantee immunity. But reducing the risk of illness can help families celebrate the season with ...

GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK has announced that the European Medicines Agency’s Committee for Medicinal Products for ...

Clin Asst Prof Sewa Duu Wen, Head and Senior Consultant of Respiratory and Critical Care Medicine at Singapore General ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

Choose the right winter health insurance plan with tips on coverage, hospitalisation, critical illness add-ons and seasonal protection.